Dear colleagues,

We are pleased to announce that Cancers will be awarding two Travel Awards to junior scientists. The applications will be assessed by an evaluation committee, consisting of senior scholars from the Cancers Editorial Board.

This prize provides financial support for the winners to attend an online or physical international conference in the field of oncology to be held in 2022, in order to hold a presentation, present a poster, or both.

Candidate Requirements:

– Instructors, postdoctoral fellows or Ph.D. students;
– Plans to attend an international conference in 2022 (oral presentation or poster).

Required Application Documents:

– Information of the conference the applicant is planning to attend and the abstract that will be submitted;
– Curriculum Vitae and list of publications;
– Justification letter describing the focus of the research (max. 800 words);
– Letter of recommendation from the supervisor, research director, or department head, which also confirms the applicant’s status as a postdoctoral fellow/Ph.D. student.

The winners will be awarded 800 CHF each and a certificate, and they will also have the chance to publish one paper free of charge in Cancers in 2022.

Please submit your application online, through the above “apply” button, by 28 February 2022. Prizes will be awarded at the end of April 2022 and announced on Cancers website.

Dear Colleagues,

On behalf of the Editor-in-Chief, Prof. Dr. Samuel C. Mok, we wish to acknowledge our reviewers who so generously give their time to review papers submitted to Cancers by presenting an award to those reviewers who have demonstrated exceptional dedication, professionalism, and timeliness in reviewing manuscripts for Cancers.

What are the prerequisites to be eligible for this award?

• All of the reviewers for Cancers in 2021 will be automatically included.

Select Criteria:

• Number of review reports (only first review reports are considered)
• Review quality based on the rating given in SuSy
• Review speed

What will the winners receive?

There will be five winners this year, and each will receive the following:

• 500 Swiss francs;
• An opportunity to publish a paper in Cancers in 2022 without publication fees;
• An electronic certificate.

When will the winners be announced?

• The winners will be announced at the end of March 2022 on the journal website.

How can I make myself eligible?

• If you have not yet reviewed papers for Cancers but would like to do so, you can register as a reviewer through the following link: https://susy.mdpi.com/volunteer/profile/edit.

We are pleased to announce that the Cancers 2021 Ph.D. Thesis Award is now open for applications. The award is for the student who has produced the best Ph.D. thesis and made the most outstanding contribution to scientific and/or technological knowledge in the field of oncology. All applications will be assessed by an evaluation committee led by the editor-in-chief, Prof. Dr. Samuel Mok.

Eligibility Criteria:

– The Ph.D. thesis should be original work;
– The Ph.D. thesis should be defended between 1 September 2020 and 31 August 2021.

Required Information for Application:

– An executive summary of the Ph.D. thesis, in English and around 3000 words;
– A letter from the Ph.D. supervisor recommending the candidate for consideration for this award;
– A CV of the candidate, including a list of publications connected with the thesis;
– An electronic copy of the Ph.D. thesis;
– A scanned copy of the Ph.D. diploma.

The winner will be awarded 800 CHF and a certificate, and they will also have the chance to publish one paper free of charge in Cancers during the period 2021–2022.

Please submit your applications and materials through the above “apply” button by 30 September 2021. The winner will be announced by the end of November 2021.

Dear Colleagues,

The editorial team would like to congratulate the winners of the Cancers 2019 Best Paper Awards, who were chosen by a Selection Committee chaired by the Editor-in-Chief, Prof. Dr. Samuel C. Mok. Following a review process by the Evaluation Committee, four winners were selected. The recipients of the “Cancers 2019 Best Paper Awards” are as follows:

Article:

CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid (doi: 10.3390/cancers11050674)
By: Lynsey M. Whilding, Leena Halim, Benjamin Draper, Ana C. Parente-Pereira, Tomasz Zabinski, David Marc Davies and John Maher
Cancers 2019, 11(5), 674.

Blockade of Lactate Dehydrogenase-A (LDH-A) Improves Efficacy of Anti-Programmed Cell Death-1 (PD-1) Therapy in Melanoma (doi: 10.3390/cancers11040450)
By: Saeed Daneshmandi, Barbara Wegiel and Pankaj Seth
Cancers 2019, 11(4), 450.

Review：

Gut Microbiota and Cancer: From Pathogenesis to Therapy (doi: 10.3390/cancers11010038)
By: Silvia Vivarelli, Rossella Salemi, Saverio Candido, Luca Falzone, Maria Santagati, Stefania Stefani, Francesco Torino, Giuseppe Luigi Banna, Giuseppe Tonini and Massimo Libra
Cancers 2019, 11(1), 38.

PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences are Emerging—A Literature Review (doi: 10.3390/cancers11071033)
By: Gabrielle Planes-Laine, Philippe Rochigneux, François Bertucci, Anne-Sophie Chrétien, Patrice Viens, Renaud Sabatier and Anthony Gonçalves
Cancers 2019, 11(7), 1033.

Each winner (corresponding author) will receive 500 CHF and a chance to publish a paper free of charge in Cancers in 2021 after the normal peer-review procedure.

Please join us in congratulating the winners of Cancers 2019 Best Paper Awards. We would also like to take this opportunity to thank all of our authors for their continued support of Cancers.

Dear Colleagues,

We are pleased to announce the winners of the Cancers 2020 Outstanding Reviewer Awards. The Cancers Editorial Board and Editorial Team would like to gratefully acknowledge the time and energy dedicated by reviewers in checking the manuscripts submitted to Cancers. It is due to their efforts that the high quality of the journal and quick turnaround are maintained.

Dr. Pedro Miguel Rodrigues, Biodonostia Health Research Institute, Spain

Dr. Hua-Sheng Chiu, Texas Children’s Cancer Center, Baylor College of Medicine, Houston, USA

They will receive the following:
– An electronic certificate;
– 1000 Swiss francs (CHF);
– An offer to publish a paper free of charge in Cancers after peer review before the end of 2021.

Kind regards,

Dear Colleagues,

We are pleased to announce that the winners of the Cancers 2020 Young Investigator Awards are Dr. Lukas Bunse and Dr. Ylenia Perone.

Dr. Bunse is a postdoctoral researcher and a team leader at the Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Germany. Dr. Bunse’s research interests are in oncoimmunology, transgenic cell therapy, and vaccine development. He received his MD (Dr. med) in 2016 and his Ph.D. (Dr. rer. nat.) in 2020 and has an outstanding publication record, comprising 23 publications in peer-reviewed international journals and 2 international patents. Dr. Bunse’s Scopus Scientific Citations number is 1390 and his Hirsch index is 12. He is clearly a rising star in the field of neuro-oncology. As a single applicant, Dr. Bunse has secured funding of more than EUR 1.4 million since 2018.

Dr. Perone MD, Ph.D., is a Clinical Research Fellow in Medical Oncology at the Imperial College London, UK. Dr. Perone’s research interests range from clinical research and clinical trials to basic scientific research in the endocrine-related cancer field. Dr. Perone was awarded a prestigious Cancer Research UK (CRUK) Ph.D. Fellowship at Imperial College London and received her Ph.D. degree in 2020. Her research aimed to understand the interplay between epigenetics and lipid metabolism in endocrine therapy-resistant nuclear receptor-positive cancer. She is clearly a rising star in the field with an outstanding record of achievement for a young investigator at this stage of her career comprising ten publications in peer-reviewed international journals, two invited oral presentations at International Conferences, and twelve Awards and Prizes.

This is an outstanding achievement in today’s competitive environment. Please join us in congratulating Dr. Bunse and Dr. Perone for their outstanding achievements.

As the awardee, Dr. Bunse and Dr. Perone will receive an honorarium of 2000 CHF, an offer to publish a paper free of charge before 2021 in Cancers after peer review, and an electronic certificate.

We would like to thank all the nominators and nominees from various fields of study for their participation and all the Award Committee Members for their evaluation of the many excellent nominations.

The following four nominees will be given a 15% discount on a paper to be published in Cancers in 2021.

• Arutha Kulasinghe, Queensland University of Technology, Australia
• John Charles Rotondo, University of Ferrara, Italy
• Mohamed Saad, Monash University, Australia

Prof. Dr. Samuel C. Mok
Editor-in-Chief, Cancers

Dear Colleagues,

We are pleased to announce that the winner of the 2018 Cancers Young Investigator Award is Dr. Sarah McClelland. Dr. McClelland will receive an award of 2000 Swiss Francs, an offer to publish a paper free of charge without a fixed deadline in Cancers, and an engraved plaque.

Dr. Sarah McClelland is a lecturer in Molecular Oncology at the Barts Cancer Institute, Queen Mary University of London. Dr. McClelland received her Ph.D. degree in 2003 and worked as a postdoctoral research fellow from 2003 to 2013. In 2013 she established her laboratory at the Barts Cancer Institute, Queen Mary University of London. Here, her research aims to understand causes of chromosome mis-segregation in the context of ovarian and pancreatic cancer, and also to characterise fundamental mechanisms controlling genetic stability. Her laboratory recently discovered that individual human chromosomes behave non-randomly during error-prone mitosis, which has important implications for understanding the widespread chromosome changes in cancer. Dr. McClelland’s track record of achievements is impressive for a young investigator at this stage of her career.

We would like to thank all the applicants in various fields of study for their participation and the Award Committee members for reviewing the numerous high-quality applications received.

Prof. Dr. Samuel C. Mok
Cancers Editorial Office
Editor-in-Chief

Dear Colleagues,

As Editor-in-Chief of the open access journal Cancers, it is my pleasure to announce that the winner of the 2017 Cancers Travel Award is Dr. Cecilia Leung, Ph.D. Dr. Leung is a postdoctoral researcher in Prof. Giulio Draetta’s laboratory at the University of Texas MD Anderson Cancer Center, Houston, TX, USA.

On behalf of Cancers, she will be supported with 1000 Swiss Francs towards travel expenses to attend the American Association for Cancer Research (AACR) Annual Meeting 2017 to be held at Washington, D.C., USA.

Dr. Leung’s current research focuses on epigenetic regulation of pancreatic cancer progression. Using pooled shRNA epigenome library, she and her colleagues performed an in vivo loss-of-function screen and identified COMPASS-like complexes, which have specific H3K4 methyltransferase activity, to be key oncogenic drivers of pancreatic cancer. Dr. Leung has co-authored ten publications of which three are as first author, many in high profile journals (such as Nature Communications, Cancer Research and Clinical Cancer Research). She has also already been the recipient of numerous awards.

Prof. Samuel C. Mok
Editor-in-Chief